Revised forecast
Fiscal year ending March 2026 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
No non-consolidated earnings forecast was disclosed. The reasons for the difference from the previous fiscal year's actual results include increased production capacity, expanded sales in the energy, food and pharmaceutical sectors, the capture of maintenance demand, and deliveries of large-scale projects. Net income decreased due to extraordinary losses, including plant restructuring costs.
Plant restructuring costs and other items. Amount: Not disclosed
| Item | Details |
|---|---|
| Net Sales | 6,196 |
| Operating profit | 789 |
| Ordinary income | 674 |
| Profit attributable to owners of the parent | -106 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Previous-period results | Net sales: ¥31,104 million; operating income: ¥1,683 million; ordinary income: ¥2,381 million; net income: ¥3,159 million; basic earnings per share: ¥113.41 |
| Reason for the revision | No non-consolidated earnings forecast was disclosed. The reasons for the difference from the previous fiscal year's actual results include increased production capacity, expanded sales in the energy, food and pharmaceutical sectors, the capture of maintenance demand, and deliveries of large-scale projects. Net income decreased due to extraordinary losses, including plant restructuring costs. |
| Details and amount of extraordinary loss | Plant restructuring costs and other items. Amount: Not disclosed |
| Consolidated / non-consolidated | Non-consolidated |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales and operating income increased due to the stable operation of the Ikoma facility, increased production capacity through the restructuring of the Konoike facility, responses to demand for energy savings and labor savings, expanded sales in the energy, food and pharmaceutical sectors, the capture of maintenance demand, and deliveries of large-scale projects in the process engineering business. Net income decreased because, although extraordinary gains including gains on the sale of cross-shareholdings were recorded, extraordinary losses including plant restructuring costs were also recorded.